跳至主要内容
临床试验/NCT05328986
NCT05328986已完成不适用

Multi-center Assessment of Survivors for Kidney Disease After COVID-19

Icahn School of Medicine at Mount Sinai5 个研究点 分布在 1 个国家目标入组 1,753 人开始时间: 2020年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,753
试验地点
5
主要终点
estimated Glomerular Filtration Rate (eGFR)

研究概览

简要总结

To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults, age ≥18 years
  • Confirmed diagnosis of COVID-19

排除标准

  • No confirmed diagnosis of COVID-19

结局指标

主要结局

estimated Glomerular Filtration Rate (eGFR)

时间窗: yearly for 4 years after COVID exposure

Kidneys filter blood by removing waste and extra water to make urine. The kidney's filtration rate, called the glomerular filtration rate (GFR), shows how well the kidneys are filtering. A normal GFR is 60 or higher.

次要结局

  • Urine Albumin-to-Creatinine Ratio (UACR)(yearly for 4 years after COVID exposure)
  • Urine protein/creatinine ratio (UPCR)(yearly for 4 years after COVID exposure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Evren Azeloglu

Associate Professor of Medicine

Icahn School of Medicine at Mount Sinai

研究点 (5)

Loading locations...

相似试验